EN PL

FDA: Draft guideline: Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors

17.10.2013
The purpose of this guidance is to help prescription drug and biologic product manufacturers minimize medication errors associated with their products. This guidance focuses on safety aspects of the container label and carton labeling design, and provides a set of principles and recommendations for ensuring that critical elements of a product’s container labels and carton labeling are designed to promote safe dispensing, administration, and use of the product.